Raymond James Upgrades J&J (JNJ) to Outperform

Article Stock Quotes (1) Comments (0)

An analyst at Raymond James upgraded shares of Johnson & Johnson (NYSE: JNJ) from Market Perform to Outperform Wednesday morning.

Investors are bidding up shares of J&J this morning following news late Tuesday the company gained regulatory approval for its Synthes acquisition. The company also announced its unit Janssen entered into an accelerated buyback plan for up to $12.9 billion. With a couple hours left in the pre-market session, J&J shares are up 2 percent to $64.35.

For an analyst ratings summary and ratings history on Johnson & Johnson click here. For more ratings news on Johnson & Johnson click here.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: Leerink Swann Upgrades Bristol-Myers Squibb Co. (BMY) to Outperform
• Stephens Upgrades Heartland Payment Systems (HPY) to Overweight
• Janssen Oncology Data to be Presented at 2013 American Society of Clinical Oncology (ASCO) Annual Meeting, Including ZYTIGA®, Ibrutinib and Daratumumab Data

Create E-mail Alert Related Categories

Upgrades

Related Entities

Raymond James

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?